Cancer Referral and Treatment Activity 2010–2015: A Population-Based Study from Vancouver Island

Savage, Philip; Holloway, Caroline L.; Lindsay, Grace; Shubrook, K.; Jones, Christopher I.; Fung, Mayo; Schaff, Kimberly; Anderson, Helén; Nystedt, Kelly E.; Rauw, Jennifer

doi:10.3747/co.23.3306

Cited by 5 publications

(3 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The number of VADs being inserted is growing year on year. This growth is due to the increasing prevalence of lifestyle diseases, the treatment of infections, various other diseases such as cystic fibrosis (Hurley et al, 2014) and tuberculosis (Ravimohan et al, 2018), and a rise in the number of chemotherapy procedures requiring long-term IV therapies (Torre et al, 2015;Savage et al, 2016). To provide an idea of this growth, the most recent reports estimate that the global VAD market is projected to grow from 3,034 billion pounds sterling in 2017 to 4,272 billion pounds sterling by 2022 (Markets and Markets, 2016).…”

Section: 1: Context and Background For The Researchmentioning

confidence: 99%

‘Pinholes in my arms’: the vicious cycle of vascular access

Kelly

Snowden

2021

Br J Nurs

View full text Add to dashboard Cite

Background: Vascular access devices (VADs) are essential for delivery of intravenous therapies. There are notable gaps in the literature regarding a focus on patient experience and meaning-making related to living with a VAD, specifically a central venous access device (CVAD). Aims: To explore how patients make sense of living with a CVAD. Methods: This study followed an interpretive phenomenological analysis (IPA) approach. Purposive sampling was used to identify 11 cancer patients who had a CVAD in situ. One-to-one semi-structured interviews were performed. Interviews were digitally recorded, transcribed and analysed by the lead author. Findings: Four superordinate themes were identified: the self under attack; being rescued/being robbed; protection of others/protection of self; bewilderment and dismay at lack of staff competence. Conclusion: Having a CVAD affects the psychological, social, and personal self and impacts on self-esteem and self-image. Despite this, CVADs are accepted by patients and are eventually ‘embodied’ by them.

show abstract

Section: 1: Context and Background For The Researchmentioning

confidence: 99%

‘Pinholes in my arms’: the vicious cycle of vascular access

Kelly

Snowden

2021

Br J Nurs

View full text Add to dashboard Cite

show abstract

“…Our recent publication confirms the overall impact on overall cancer treatment activity. The data summarised in Table 1a and 1b indicate that during the period 2010e2015 patient referrals increased by 17.7%, radiotherapy courses by 6.1%, oral chemotherapy prescriptions by 22.9% and intravenous systemic cancer treatment activity by 62.0% [10].…”

Section: Increases In Overall Treatment Activitymentioning

confidence: 99%

Economic and Logistic Challenges of Modern Oncology Healthcare

Savage

2017

Clinical Oncology

Self Cite

View full text Add to dashboard Cite

The past decade has seen many important advances in medical care. However, this era of clinical progress has coincided with a period of slow economic growth, which has limited the finances for expanding healthcare in many countries.In the UK, this growing financial was recognised in the 2009 National Health Service (NHS) Chief Executive's report, which described a plan, now termed the 'Nicholson Challenge', to use NHS efficiency savings to meet rising demand [1]. This plan was further developed in the 2010e2011 Health Committee Report [2], which shared the aim 'to meet rising demand and improve the quality of services without a corresponding increase in funding'. Although difficulties in delivering the planned efficiencybased savings are apparent [3], it is also of value to review the scale of the financial challenges that result from recent medical progress.

show abstract

“…A recent Canadian study indicates that there was an approximate 60% increase in oncology outpatient drug delivery activity over the five-year period from 2010 to 2015. 4…”

Section: Introductionmentioning

confidence: 99%

The impact of new cancer drug therapies on site specialised cancer treatment activity in a UK cancer network 2014–2018

Bhimani¹,

Philipps²,

Simpson³

et al. 2019

J Oncol Pharm Pract

View full text Add to dashboard Cite

Introduction Drug treatment for cancer has changed dramatically over the past decade with many new drugs often with multiple applications. More recently, the detailed pathway for approval from the National Institute for Health and Care Excellence (NICE) in the UK has been simplified. To explore how these changes have impacted on systemic anti-cancer therapy tumour site-specific prescribing and workload activities, we have reviewed the prescribing records for 2014–2018 in a UK cancer network. Methods Information about the numbers of new systemic anti-cancer therapy drugs and NICE approvals were obtained from print editions of the British National Formulary (BNF) and the NICE website. Data on the numbers of new chemotherapy courses and individual treatment-related attendances were obtained from the cancer network Chemocare electronic prescribing system. Results During the five-year study period, there were 49 new systemic anti-cancer therapy drugs for all tumour types, and a total of 65 NICE technology approvals for solid tumour indications. Overall numbers of treatment courses increased by 40.7% and total treatment-related visits by 80.6%. There was a wide variation across tumour types with the highest number of increased visits seen for melanoma (349.3%) and prostate cancer (242.3%), but in contrast, no appreciable increases were seen for lower gastrointestinal cancers or small cell lung cancer. Conclusion The study confirms the major impact of the arrival of new drug technology and positive NICE appraisals on increasing systemic anti-cancer therapy prescribing and chemotherapy unit activity. The data in this study may be of help in planning for future service delivery planning and workforce configurations.

show abstract

Cancer Referral and Treatment Activity 2010–2015: A Population-Based Study from Vancouver Island

Abstract: IntroductionThe years since 2005 have seen major changes in cancer treatment and significant increases in the

Cited by 5 publications

References 9 publications

‘Pinholes in my arms’: the vicious cycle of vascular access

‘Pinholes in my arms’: the vicious cycle of vascular access

Economic and Logistic Challenges of Modern Oncology Healthcare

The impact of new cancer drug therapies on site specialised cancer treatment activity in a UK cancer network 2014–2018

Contact Info

Product

Resources

About